The increase of serum CRP levels is an independent risk factor of developing metabolic syndrome44, diabetes mellitus45, stroke and cardiac infarction46, and therefore it is reasonable to quantify AAT levels in a prospective manner to test AAT as the possible independent risk factor for metabolic syndrome, diabetes mellitus or stroke. This evidence concerns the gene CRP and metabolic syndrome.